Production of recombinant antitumor antibodies by HEK-293 cells

被引：1

作者：

Deyev S.M. ^{[1
]}

Stremovskiy O.A. ^{[2
,3
]}

Lukash S.V. ^{[1
]}

Karpenko D.V. ^{[2
]}

Polyanovsky O.L. ^{[2
]}

Petrov R.V. ^{[1
]}

机构：

[1] Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117871

[2] Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 117984

[3] Center of Medical Studies, Oslo University, Moscow

来源：

Doklady Biochemistry and Biophysics | 2006年 / 406卷 / 1期

基金：

俄罗斯基础研究基金会;

关键词：

Variable Domain; DOKLADY Biochemistry; Recombinant Antibody; Leader Peptide; Constant Domain;

D O I：

10.1134/S1607672906010121

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用

页码：44 / 46

页数：2

共 12 条

[1]

Reichert J., Pavlou A., Nature Rev., 3, pp. 383-384, (2004)

[2]

Bell R., Anti-Cancer Drugs, 12, pp. 561-568, (2001)

[3]

Todorovska A., Roovers R.C., Dolezal O., Et al., J. Immunol. Meth., 1-2, pp. 47-66, (2001)

[4]

Deyev S.M., Waibel R., Lebedenko E.N., Et al., Nature Biotechnol, 21, 12, pp. 1486-1492, (2003)

[5]

Martsev S.P., Dubnovitsky A.P., Stremovsky O.A., Et al., FEBS Lett., 8, pp. 117-128, (2002)

[6]

Martsev S.P., Tsybovsky Y.I., Stremovsky O.A., Et al., Protein Eng. Design Select., 17, 1, pp. 85-93, (2004)

[7]

Semenyuk E.G., Stremovskii O.A., Balandin T.G., Et al., Mol. Biol., 37, 5, pp. 916-923, (2003)

[8]

Eigenbrot C., Randal M., Presta L., Et al., J. Mol. Biol., 229, pp. 969-995, (1993)

[9]

Deyev S.M., Polanovsky O.L., Lieber A., Radko B.V., FEBS Lett., 330, 2, pp. 111-113, (1993)

[10]

Rodin D.V., Rad'ko B.V., Kolesnikov V.A., Et al., Biochimie, 86, pp. 939-943, (2004)

← 1 2 →